Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Maike Schuh Insider Profile
4 Followers
Maike Schuh, Chief Financial Officer at Evonik, holds ― shares in Evonik (Ticker: GB:0QDS). Most recently, Maike Schuh Bought €4,775 shares of Evonik on Oct 01, 2024 for an estimated value of 99.99K.
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
+7.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Maike Schuh does not currently own shares as a corporate insider.
A breakdown of Maike Schuh's holdings
Insider Roles
Chief Financial Officer
Roles that Maike Schuh holds in companies
Most Profitable Insider Trade
The most profitable trade made by Maike Schuh
Maike Schuh's Trading History
List of latest transactions for each holding click on a transaction to see Maike Schuh's performance on stock
You May Also Like
Maike Schuh insider profile FAQ
What is the percentage of profitable transactions made by Maike Schuh?
The percentage of profitable transactions made by Maike Schuh is 80%.
What is the average return per transaction made by Maike Schuh?
The average return per transaction made by Maike Schuh is 7.70%.
What stocks does Maike Schuh hold?
Maike Schuh holds: GB:0QDS stocks.
What was Maike Schuh’s latest transaction?
Maike Schuh latest transaction was an Informative Buy of €99.99K.
What was Maike Schuh's most profitable transaction?
Maike Schuh’s most profitable transaction was an Informative Buy of GB:0QDS stock on November 28, 2023. The return on the trade was 23.10%.
What is Maike Schuh's role in Evonik?
Maike Schuh's role in Evonik is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.